- Home
- XPOF vs ALDX Comparison
XPOF vs ALDX Comparison
Compare XPOF & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPOF
- ALDX
- Stock Information
- Founded
- XPOF 2017
- ALDX 2004
- Country
- XPOF United States
- ALDX United States
- Employees
- XPOF N/A
- ALDX N/A
- Industry
- XPOF Services-Misc. Amusement & Recreation
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- XPOF Consumer Discretionary
- ALDX Health Care
- Exchange
- XPOF Nasdaq
- ALDX Nasdaq
- Market Cap
- XPOF 388.8M
- ALDX 319.4M
- IPO Year
- XPOF 2021
- ALDX 2014
- Fundamental
- Price
- XPOF $15.51
- ALDX $5.41
- Analyst Decision
- XPOF Buy
- ALDX Strong Buy
- Analyst Count
- XPOF 10
- ALDX 2
- Target Price
- XPOF $16.85
- ALDX $10.00
- AVG Volume (30 Days)
- XPOF 376.4K
- ALDX 389.5K
- Earning Date
- XPOF 11-07-2024
- ALDX 11-15-2024
- Dividend Yield
- XPOF N/A
- ALDX N/A
- EPS Growth
- XPOF N/A
- ALDX N/A
- EPS
- XPOF N/A
- ALDX N/A
- Revenue
- XPOF $326,668,000.00
- ALDX N/A
- Revenue This Year
- XPOF $0.85
- ALDX N/A
- Revenue Next Year
- XPOF $9.33
- ALDX $25.36
- P/E Ratio
- XPOF N/A
- ALDX N/A
- Revenue Growth
- XPOF 15.41
- ALDX N/A
- 52 Week Low
- XPOF $7.40
- ALDX $2.20
- 52 Week High
- XPOF $18.95
- ALDX $6.55
- Technical
- Relative Strength Index (RSI)
- XPOF 70.67
- ALDX 47.99
- Support Level
- XPOF $11.37
- ALDX $4.93
- Resistance Level
- XPOF $12.92
- ALDX $5.74
- Average True Range (ATR)
- XPOF 0.78
- ALDX 0.32
- MACD
- XPOF 0.20
- ALDX -0.02
- Stochastic Oscillator
- XPOF 83.88
- ALDX 33.06
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix, a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.